Ansa Biotechnologies, a California-based start-up focused on updating DNA synthesis technologies, is advancing toward the launch of a customizable DNA synthesis service, stemming from the development of a novel synthesis method.
A paper published in the journal Science on August 8 suggests that it may be possible to speed up the drug discovery process.
